Primary Site >> Biliary tract Cancer
Gene >> IMP3
|
|
|
|
|
|---|---|---|---|---|
|
Ref: IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas. PMID: 19467694 |
Ref: [Diagnosis of tumours of the liver and the biliary tract: new tissue and serum markers]. PMID: 21814862 |
Ref: Expression of insulin-like growth factor II mRNA-binding protein 3 predicts early recurrence and poor prognosis in intrahepatic cholangiocarcinoma. PMID: 23246869 |
Ref: Immunohistochemical distinction between intrahepatic cholangiocarcinoma and pancreatic ductal adenocarcinoma. PMID: 24439226 Ref: IMP3 expression is associated with poor outcome and epigenetic deregulation in intrahepatic cholangiocarcinoma. PMID: 24745619 |
Ref: Insulin-like growth factor II mRNA-binding protein 3 (IMP3) is a marker that predicts presence of invasion in papillary biliary tumors. PMID: 28089541 Ref: Prognostic value of high IMP3 expression in solid tumors: a meta-analysis. PMID: 28652767 Ref: IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer. PMID: 29163784 |